[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Facial Rejuvenation Market, 2012-2023

January 2018 | 205 pages | ID: F57AA429432EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Facial Rejuvenation Market

Facial rejuvenation is a combination of medical and cosmetic procedure that is carried out the youthful appearance to the human face. Facial rejuvenation is carried by either minimally invasive or non-invasive treatment which aims to restore skin elasticity and enables maintain a youthful appearance in the neck and face region. Facial rejuvenation plays a vital role in skin protection from sun damage. In young ages, human naturally defend their bodies from sun damage by neutralization of free radicals which are reactive oxygen atoms damage the skin’s collagen. However, human bodies lose the resistance towards ultra violet radiations in older age. The signs of sun damage include wrinkles, enlarged pores, sagging skin, freckling or spotting and spider veins. Many treatments such as microabrasion, dermabrasion, topical creams, chemical peels, dermal fillers, and cosmetic surgery are available for the protection of skin from sun damage.

The global Facial Rejuvenation market is expected to grow at a significant CAGR due to increase in the global population. Rise in the disposable income levels, lifestyle changes, early onset of aging, and increasing adoption of minimally invasive or non-invasive surgical rejuvenation procedures expected fuel the facial rejuvenation market. Furthermore, simple procedures for the treatments, rise in the affordability, availability of beauty products in the market, and shorter treatment duration by patients also boost the facial rejuvenation market over the forecast period. However, lack of properly trained professionals, limited documented evidence of clinical effectiveness, and the implementation of international regulatory mandates for the standardization of cosmetic procedures are the major bottle necks for the growth of facial rejuvenation market over the forecast period.

Facial rejuvenation market is segmented based on the product type, and end-user

Based on product type, the facial rejuvenation market is segmented into the following:
  • Topical Rejuvenation Products
  • Keratolytics
  • Moisturizers
  • Retinoids
  • Sunscreens
  • Hair Removals
  • Botulinum Products
  • Dermal Fillers
  • Absorbable
  • Non absorbable
  • Chemical peels
  • Micro abrasion equipment
  • Equipment
  • Laser based equipment
  • Ultrasound-based equipment
Based on the end-user, facial rejuvenation market is segmented into the following:
  • Hospitals
  • Dermatology clinics
  • Others
Market players are adopting various key strategies that include acquisitions and mergers, collaborations, agreements, product approvals, and launching of new products to increase share in the facial rejuvenation market. For instance, in June 2009, Anika Therapeutics, signed an exclusive U.S. distribution agreement with Palo Alto, Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems’ suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anika’s injectable filler that corrects lines and wrinkles on the face. In addition, in July 2008, Johnson & Johnson received U.S. Food and Drug Administration clearance to market Evolence, an injectable collagen for treating facial wrinkles. Moreover, in April 2016, Merz Pharma made a strategic venture investment in Cytrellis Biosystems, for developing a new class of non-surgical products to combat sagging skin associated with aging.

Geographically, the facial rejuvenation market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. North America dominates the facial rejuvenation market. Owing to change in the lifestyle, increase in the healthcare expenditure and skilled professionals the region for minimally invasive surgeries. Europe facial rejuvenation market holds a dominant share attributed to increase in the aging population, technological developments in the facial rejuvenation procedures such as minimally invasive or non-surgical procedures might fuel the market in European region over the forecast period. Asia-Pacific accounts for the significant share due to increase in the population companies setting up manufacturing facilities in the region. In addition, rising awareness about skin problems is also supporting the growth of facial rejuvenation market in Asia-Pacific region over the forecast period.

Some of the players in facial rejuvenation market are Biopolymer GmbH & Co KG (Germany), Merz GmbH & Co. KGaA (Germany), Lumenis (U.S.), Revance Therapeutics, Inc. (U.S,), Speciality European Pharma (U.K.), Mentor Worldwide LLC (U.K.), Anika Therapeutics, Inc. (U.S.), Contura International A/S (Denmark), Cynosure, Inc. (U.S.), Fibrocell Science Inc. (U.S,), and Galderma S/A (Switzerland) to name a few.
1. EXECUTIVE SUMMARY

2. GLOBAL FACIAL REJUVENATION MARKET INTRODUCTION

2.1. Global Facial Rejuvenation Market – Taxonomy
2.2. Global Facial Rejuvenation Market –Definitions
  2.2.1. Product
  2.2.2. End-Use

3. GLOBAL FACIAL REJUVENATION MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Facial Rejuvenation Market Dynamics – Factors Impact Analysis
3.6. Global Facial Rejuvenation Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe
  3.6.3. Japan
3.7. Global Facial Rejuvenation Market – Product Pipeline Analysis

4. GLOBAL FACIAL REJUVENATION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL FACIAL REJUVENATION MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Topical Rejuvenation Products
  5.1.1. Keratolytics
    5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.1.3. Market Opportunity Analysis
  5.1.2. Moisturizers
    5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.2.3. Market Opportunity Analysis
  5.1.3. Retinoids
    5.1.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.3.3. Market Opportunity Analysis
  5.1.4. Sunscreens
    5.1.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.4.3. Market Opportunity Analysis
  5.1.5. Hair Removals
    5.1.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.1.5.3. Market Opportunity Analysis
5.2. Botulinum Products
    5.2.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.2.1.3. Market Opportunity Analysis
5.3. Dermal Fillers
  5.3.1. Absorbable
    5.3.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.3.1.3. Market Opportunity Analysis
  5.3.2. Non absorbable
    5.3.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.3.2.3. Market Opportunity Analysis
5.4. Chemical peels
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Micro abrasion equipment
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Equipment
  5.6.1. Laser based equipment
    5.6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    5.6.1.3. Market Opportunity Analysis
5.7. Ultrasound-based equipment
  5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis

6. GLOBAL FACIAL REJUVENATION MARKET FORECAST, BY END-USE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Hospital Pharmacies
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Dermatology Clinics
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Others
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL FACIAL REJUVENATION MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. North America
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use, and Region, 2017 – 2023

8. NORTH AMERICA FACIAL REJUVENATION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.1.1. Topical Rejuvenation Products
    8.1.1.1. Keratolytics
    8.1.1.2. Moisturizers
    8.1.1.3. Retinoids
    8.1.1.4. Sunscreens
    8.1.1.5. Hair Removals
  8.1.2. Botulinum Products
  8.1.3. Dermal Fillers
    8.1.3.1. Absorbable
    8.1.3.2. Non absorbable
  8.1.4. Chemical peels
  8.1.5. Micro abrasion equipment
  8.1.6. Equipment
    8.1.6.1. Laser based equipment
  8.1.7. Ultrasound-based equipment
  8.1.8. Others
8.2. End-Use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  8.2.1. Hospital Pharmacies
  8.2.2. Dermatology Clinics
  8.2.3. Others
8.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  8.3.1. U.S.
  8.3.2. Canada
8.4. North America Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2017 – 2023
8.5. North America Facial Rejuvenation Market Dynamics – Trends

9. EUROPE FACIAL REJUVENATION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Topical Rejuvenation Products
    9.1.1.1. Keratolytics
    9.1.1.2. Moisturizers
    9.1.1.3. Retinoids
    9.1.1.4. Sunscreens
    9.1.1.5. Hair Removals
  9.1.2. Botulinum Products
  9.1.3. Dermal Fillers
    9.1.3.1. Absorbable
    9.1.3.2. Non absorbable
  9.1.4. Chemical peels
  9.1.5. Micro abrasion equipment
  9.1.6. Equipment
    9.1.6.1. Laser based equipment
  9.1.7. Ultrasound-based equipment
  9.1.8. Others
9.2. End-Use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Hospital Pharmacies
  9.2.2. Dermatology Clinics
  9.2.3. Others
9.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Germany
  9.3.2. UK
  9.3.3. France
  9.3.4. Spain
  9.3.5. Italy
  9.3.6. Russia
  9.3.7. Poland
  9.3.8. Rest of Europe
9.4. Europe Facial Rejuvenation Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product, By End-Use and Country, 2017 – 2023
9.5. Europe Facial Rejuvenation Market Dynamics – Trends

10. ASIA-PACIFIC FACIAL REJUVENATION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Topical Rejuvenation Products
    10.1.1.1. Keratolytics
    10.1.1.2. Moisturizers
    10.1.1.3. Retinoids
    10.1.1.4. Sunscreens
    10.1.1.5. Hair Removals
  10.1.2. Botulinum Products
  10.1.3. Dermal Fillers
    10.1.3.1. Absorbable
    10.1.3.2. Non absorbable
  10.1.4. Chemical peels
  10.1.5. Micro abrasion equipment
  10.1.6. Equipment
    10.1.6.1. Laser based equipment
  10.1.7. Ultrasound-based equipment
  10.1.8. Others
10.2. End-Use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Hospital Pharmacies
  10.2.2. Dermatology Clinics
  10.2.3. Others
10.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  10.3.1. Japan
  10.3.2. China
  10.3.3. India
  10.3.4. ASEAN
  10.3.5. Australia & New Zealand
  10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2017 – 2023
10.5. Asia-Pacific Facial Rejuvenation Market Dynamics – Trends

11. LATIN AMERICA FACIAL REJUVENATION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Topical Rejuvenation Products
    11.1.1.1. Keratolytics
    11.1.1.2. Moisturizers
    11.1.1.3. Retinoids
    11.1.1.4. Sunscreens
    11.1.1.5. Hair Removals
  11.1.2. Botulinum Products
  11.1.3. Dermal Fillers
    11.1.3.1. Absorbable
    11.1.3.2. Non absorbable
  11.1.4. Chemical peels
  11.1.5. Micro abrasion equipment
  11.1.6. Equipment
    11.1.6.1. Laser based equipment
  11.1.7. Ultrasound-based equipment
  11.1.8. Others
11.2. End-Use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Hospital Pharmacies
  11.2.2. Dermatology Clinics
  11.2.3. Others
11.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Brazil
  11.3.2. Mexico
  11.3.3. Argentina
  11.3.4. Venezuela
  11.3.5. Rest of Latin America
11.4. Latin America Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2017 – 2023
11.5. Latin America Facial Rejuvenation Market Dynamics – Trends

12. MIDDLE EAST AND AFRICA FACIAL REJUVENATION MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Product Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Topical Rejuvenation Products
    12.1.1.1. Keratolytics
    12.1.1.2. Moisturizers
    12.1.1.3. Retinoids
    12.1.1.4. Sunscreens
    12.1.1.5. Hair Removals
  12.1.2. Botulinum Products
  12.1.3. Dermal Fillers
    12.1.3.1. Absorbable
    12.1.3.2. Non absorbable
  12.1.4. Chemical peels
  12.1.5. Micro abrasion equipment
  12.1.6. Equipment
    12.1.6.1. Laser based equipment
  12.1.7. Ultrasound-based equipment
  12.1.8. Others
12.2. End-Use Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. Hospital Pharmacies
  12.2.2. Dermatology Clinics
  12.2.3. Others
12.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.3.1. Gulf Cooperation Council (GCC) Countries
  12.3.2. Israel
  12.3.3. South Africa
  12.3.4. Rest of MEA
12.4. MEA Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2017 – 2023
12.5. MEA Facial Rejuvenation Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. Biopolymer GmbH & Co KG (Germany)
  13.2.2. Merz GmbH & Co. KGaA (Germany)
  13.2.3. Lumenis (U.S.)
  13.2.4. Revance Therapeutics, Inc. (U.S)
  13.2.5. Speciality European Pharma (UK)
  13.2.6. Mentor Worldwide LLC (UK)
  13.2.7. Anika Therapeutics, Inc. (U.S.)
  13.2.8. Contura International A/S (Denmark)
  13.2.9. Cynosure, Inc. (U.S.)
  13.2.10. Fibrocell Science Inc. (U.S)
  13.2.11. Galderma S/A (Switzerland)

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS


More Publications